ELITE PHARMACEUTICALS INC /NV/ (ELTP) › Shareholders' EquityELITE PHARMACEUTICALS INC /NV/ (ELTP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$10.60M2011: -$17.87M2012: -$14.98M2013: -$8.67M2014: -$81.20M2015: -$34.73M2016: -$33.12M2017: $25.66M2018: $4.57M2019: -$2.51M2020: $10.66M2021: $16.15M2022: $25.22M2023: $28.96M2024: $57.58M2025: $53.52M$53.52M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$53.52M-7.1%2024$57.58M+98.8%2023$28.96M+14.8%2022$25.22M+56.2%2021$16.15M+51.6%2020$10.66M+524.9%2019-$2.51M-154.9%2018$4.57M-82.2%2017$25.66M+177.5%2016-$33.12M+4.6%2015-$34.73M+57.2%2014-$81.20M-836.2%2013-$8.67M+42.1%2012-$14.98M+16.2%2011-$17.87M-68.6%2010-$10.60M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share